Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
Lite Strategy, a Nasdaq-listed Litecoin treasury company, has announced leading a $1 million strategic investment in LitVM. The investment also grants governance participation rights and potential future token subscription opportunities. LitVM is a zero-knowledge Layer 2 scaling network built on Litecoin. The new funds will support its ability to introduce smart contract capabilities and a programmable application layer for Litecoin after its mainnet launch. (Globenewswire)
Nasdaq-listed Lite Strategy announced it is leading a $1 million strategic funding round for ZK Innovations—the development team behind LitVM. LitVM is building a zero-knowledge proof-based Layer 2 network for Litecoin, aiming to introduce smart contracts, decentralized finance (DeFi), real-world asset tokenization, and cross-chain liquidity to the Litecoin ecosystem.
Lite Strategy, a Nasdaq-listed Litecoin treasury company, has announced leading a $1 million strategic investment in LitVM. The investment also grants governance participation rights and potential future token subscription opportunities. LitVM is a zero-knowledge Layer 2 scaling network built on Litecoin. The new funds will support its ability to introduce smart contract capabilities and a programmable application layer for Litecoin after its mainnet launch. (Globenewswire)
Nasdaq-listed Lite Strategy announced it is leading a $1 million strategic funding round for ZK Innovations—the development team behind LitVM. LitVM is building a zero-knowledge proof-based Layer 2 network for Litecoin, aiming to introduce smart contracts, decentralized finance (DeFi), real-world asset tokenization, and cross-chain liquidity to the Litecoin ecosystem.